论文部分内容阅读
目的探讨经皮给药佐治小儿肺炎的疗效。方法选择儿科2009年9月-2010年5月收治临床诊断为小儿肺炎的患儿136例,凡合并有心力衰竭、呼吸衰竭、中毒性脑病等严重并发症的患儿均不纳入,随机分为经皮给药组与对照组,对照组64例采用常规抗感染及止咳、平喘、化痰等对症处理,治疗组72例在此治疗基础同时加用经皮给药辅助治疗并将其疗效与对照组进行比较。结果治疗组和对照组总有效率分别为93.06%和79.69%,两组相比差异有统计学意义(χ2=12.52,P<0.05),治疗组疗效明显优于对照组。结论经皮给药佐治小儿肺炎疗效肯定,且缩短使用抗生素的疗程,减少药物不良反应发生率,提高疗效,安全性好、无创伤、无毒副作用,患儿依从性好,操作简单,提高满意度,值得临床推广应用。
Objective To investigate the efficacy of transdermal administration of adjuvant pediatric pneumonia. Methods Select pediatric September 2009 - May 2010 admitted to clinical diagnosis of pediatric pneumonia in 136 cases of children, complicated by heart failure, respiratory failure, toxic encephalopathy and other serious complications were not included in children were randomly divided into Transdermal drug-treated group and control group, control group, 64 cases of conventional anti-infective and cough, asthma, phlegm and other symptomatic treatment, the treatment group of 72 patients treated with transdermal addition of adjuvant therapy and its efficacy Compared with the control group. Results The total effective rates of the treatment group and the control group were 93.06% and 79.69%, respectively, with significant difference between the two groups (χ2 = 12.52, P <0.05). The curative effect of the treatment group was obviously better than that of the control group. Conclusion Percutaneous administration of treatment of children with pneumonia is effective, and shorten the course of the use of antibiotics to reduce the incidence of adverse drug reactions and improve efficacy, safety, non-invasive, non-toxic side effects, good compliance, simple operation and improve satisfaction Degree, it is worth to promote clinical application.